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Introduction and aim Esophageal atresia is a relatively
common congenital malformation occurring one in
2500–3000 live births. The aim of this study was to determine
the frequency, type of anomaly, and mortality and to detect
the associated anomaly in patients with esophageal atresia.
Patients and methods All neonates with diagnosis of
esophageal atresia who were referred to pediatric surgery
ward of Imam Khomeini Hospital were included in this
study. Duration of this study was 10 years from 20 March
1997 to 20 March 2006. For comparison, duration of the
study was divided into two periods (1997–2001 and
2002–2006). Sex, mortality rate, associated anomalies,
type of atresia, mortality, performing thoracostomy
or gastrostomy, and packed cell infusion were studied.
Gross classification was used for typing of anomaly.
Analysis was performed using the Pearson v2-test
and analysis of variance using SPSS.
Results In this study, 198 (male = 100, female = 98)
neonates were included. The most frequent type of atresia
was type C (93.4%). Overall mortality rate was 50%.
Mortality during the first period was 54.43% and during
the second period was 47.05% (P = 0.384). The mean age
at the second surgery was significantly higher in type D
patients compared with others. The rate of gastrostomy
was significantly higher during the first period (89.87%)
compared with the second period of study (79.27%)
(P = 0.002). The rate of cervical esophagostomy was
decreased from 8.86 to 4.23% (P = 0.228).
Conclusion Mortality rate has decreased in our hospitals.
The rate of gastrostomy decreased during the second
period of study. The age at the first surgery was significantly
higher in type D classification patients. Ann Pediatr Surg
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Introduction and aim
Esophageal atresia is a relatively common congenital
malformation occurring one in 2500–3000 live births [1,2].
The most common type of anomaly is esophageal atresia
with distal tracheoesophageal fistula, which represents in
86% of patients [1]. Waterson et al. [3] reported a survival
rate of 57.6% in the early 1950s. In a 25-year study from
India, mortality has decreased from 95.4 to 41% [4]. The
aim of this study was to determine the frequency and
type of anomaly and to detect the associated anomaly
in patients with esophageal atresia.
Patients and methods
All neonates with diagnosis of esophageal atresia who
were referred to Imam Khomeini hospital were included
in this study. Duration of this study was 10 years from 20
March 1997 to 20 March 2006. For comparison, duration
of the study was divided into two periods (1997–2001 and
2002–2006). Sex, mortality rate, associated anomalies,
type of atresia, performing thoracostomy or gastrostomy,
and packed cell infusion were studied. Gross classification
was used for typing of anomaly. Analysis was performed
using the Pearson w2-test and analysis of variance using
SPSS (ver. 13.0; SPSS Inc., Chicago, Illinois, USA).
Results
In the current study, 198 (male = 100, female = 98)
neonates were included. Although there was slight
difference in male/female ratio between the first and
second period of this study, this difference was statisti-
cally not significant. During the first period of study,
60.75% (48 of 79) patients were admitted in neonatal
intensive care unit (NICU). During the second period of
study, 86.55% (103 of 119) patients were admitted in
NICU (Table 1). This difference was statistically sig-
nificant (P = 0.00002). The frequency of associated
anomalies had no significant changes over two periods
of study (P = 0.471) (Table 1). Congenital heart disease
and imperforate anus were detected in 6.09 and 5.05 of
patients, respectively. Mortality was decreased over two
periods of study, but it was not statistically significant
(Table 1). The results of comparisons between four types
of anomalies are shown in Table 2. Age at the second
surgery was significantly higher in type D patients
(P < 0.05) (Table 2).
Discussion
In our study, the mortality rate was 54.4 and 47.5% during
the first and second periods of study. In another
retrospective study from Iran, the mortality rate was
56% [5]. Mortality rate was similar in two studies. In
a study by Snajdauf et al. [6], the mortality rate was
20.2%. In the early 1950s, the survival rate was about
57.6% in the report of Waterson et al. [7]. In the study by
Beasley et al. [8], the mortality rate was decreased to 1%
in the second decade of the study. In the study by
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Seo et al. [9] on 97 patients between 1990 and 2007, the
mortality rate was 24%. In the study by Peyvasteh
et al. [10], from April 1999 to March 2000, the mortality
rate was 28.38%. In another study by the authors, the
mortality rate was decreased from 75% (1993–1996) to
58.82% (2002–2005) [11]. In study by Orford et al. [12],
the survival rate was increased from 70% (1970s) to 78%
(1990s). O’Neill et al. [13] reported 93% surveillance
among 53 neonates with esophageal atresia and tracheo-
esophageal fistula. In the study from Sweden, the total
mortality rate decreased from 33% (1969–1977) to 9%
(1978–1984) [14]. Most of the studies showed increased
survival rate following surgical repair of atresia [11,12,14].
In the study from China, 12.5% mortality rate was
observed in 48 neonates with esophageal atresia [15]. In
our study, decreased mortality rate following surgery was
observed as seen in other studies [14], but the mortality
rate in our hospitals was higher than that in other
studies [12,13]. However, decreasing mortality rate in our
study may be because of increasing number of patients
admitted to ICU for better care. This high rate of
mortality in our study may be due to limited equipments
of NICU. In addition, different mortality rates may be
the results of different birth weight and associated
anomalies.
In our study, 50.5% of patients were male and 49.5% were
female. There was a slight male predominance in the
literature [16]. In the study by David and O’Callaghan
[16], 53.9% of patients were male and 46.1% were female.
In the study by Engum et al. [17], of the 227 infants 127
(55.94%) were male and 100 (44.06%) were female. In
the study from northeast of China [15], of the 48 infants
33 were boys and male/female ratio was 2.2, which is
significantly different from previous studies. In most
studies, male is the predominant sex.
Type C atresia was the most common type of anomaly.
Our findings were similar to those of Little et al. [18].
In the study by Yang et al. [19], 80% of patients had







Male 44 (55.7) 56 (47.1) 0.249
Female 35 (44.3) 63 (52.9)
Type of atresia
A 7 (3.53) 3 (3.80) 4 (3.35) 0.524
B 2 (1.01) 1 (1.26) 1 (0.85)
C 185 (93.44) 72 (91.14) 113 (94.95)
D 4 (2.02) 3 (3.80) 1 (0.85)
Detected anomalies 109 (55.05) 46 (58.22) 63 (52.94) 0.471
Number of surgery
0 11 (5.55) 2 (2.53) 9 (7.56) 0.188
1 103 (52.02) 39 (49.36) 64 (53.79)
2 84 (42.42) 38 (48.10) 46 (38.65)
Gastrostomy
Yes 157 (79.29) 71 (89.87) 86 (72.27) 0.002
No 41 (20.71) 8 (10.13) 33 (27.73)
Gastrostomy + TEF repair + esophagoesophagostomy surgery
Yes 112 (57.14) 42 (53.84) 70 (59.32) 0.464
No 84 (42.86) 36 (46.16) 48 (40.68)
Cervical esophagostomy
Yes 12 (6.09) 7 (8.86) 5 (4.23) 0.228
No 185 (93.91) 72 (91.14) 113 (95.76)
Mortality
Yes 99 (50) 43 (54.43) 56 (47.05) 0.384
No 99 (50) 36 (45.57) 63 (52.95)
Packed cell infusion
0 97 (49.74) 42 (53.85) 55 (47.41) 0.694
1 75 (38.47) 28 (35.89) 47 (40.52)
2 22 (11.28) 8 (10.26) 14 (12.07)
3 1 (0.51) 0 0
Number of NICU admission
Yes 48 (60.75) 103 (86.55) 0.00002
No 31 (39.25) 16 (13.45)
Duration of NICU
admission
5.47 ± 5.38 5.31 ± 6.16 5.54 ± 5.00 0.807
Duration of hospital
admission
12.92 ± 10.24 13.04 ± 11.70 12.84 ± 9.19 0.895
NICU, neonatal intensive care unit; TEF, tracheoesophageal fistula.
Table 2 Sex distribution, associated anomalies, and demographic features of different types of atresia
A B C D P
Sex
Male 4 (57.14) 1 (50) 94 (50.81) 1 (25) 0.760
Female 3 (42.86) 1 (50) 91 (49.19) 3 (75)
Detected anomalies 3 (42.86) 2 (100) 103 (55.68) 1 (25) 0.315
Number of surgery
0 0 0 11 (5.95) 0 0.748
1 5 (28.58) 2 (100) 94 (50.81) 2 (50)
2 2 (71.42) 0 80 (43.24) 2 (50)
Gastrostomy
Yes 6 (85.71) 2 (100) 147 (79.46) 2 (50) 0.425
No 1 (14.29) 0 38 (20.54) 2 (50)
Gastrostomy + closure of TEF + esophagostomy surgery
Yes 1 (14.29) 0 108 (59.01) 3 (75) 0.034
No 6 (85.71) 2 (100) 75 (40.98) 1 (25)
Cervical esophagostomy
Yes 4 (57.14) 0 8 (4.35) 0 NA
No 3 (42.86) 2 (100) 176 (95.65) 4 (100)
Packed cell transfusion
0 4 (57.14) 2 (100) 90 (49.18) 1 (33.33) 0.877
1 3 (42.86) 0 71 (38.8) 1 (33.33)
2 0 0 21 (11.47) 1 (33.34)
3 0 0 1 (0.55) 0
Age at 1st surgery 2.57 ± 787 2.00 ± 1.414 3.41 ± 2.941 7.00 ± 6.245 0.628
Age at 2nd surgery 7.50 ± 0.707 – 9.69 ± 5.658 14.00 ± 16.513 0.000
Duration of NICU stay 4.67 ± 2.88 3 5.45 ± 5.41 9.5 ± 7.77 0.709
Duration of hospital stay 9.57 ± 5.94 3.00 ± 1.41 13.13 ± 10.44 14.00 ± 4.89 0.435
NA, not applicable; NICU, neonatal intensive care unit; TEF, tracheoesophageal fistula.
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type D atresia. In the Deurloo et al.’s [20] study, between
1947 and 2000, 88.7% of the 371 patients had type C
atresia. In Zhang et al.’s [15] study, most of the patients
were Gross type C. The results of studies using the Gross
classification were similar [1,15].
The age at the first surgery in type D esophageal atresia
was significantly higher than that in other types. It is
expected because there is usual occurrence of respiratory
infection with this type [1].
In our study, there were seven patients with type A
esophageal atresia. Of the patients, six (85.71%) and four
(57.14%) patients underwent gastrostomy and cervical
esophagostomy, respectively. In our study, 50% mortality
rate was observed over both periods of study. In the study
by Burjonrappa et al. [21], 15 patients were with type A
esophageal atresia, 13 patients underwent gastrostomy as
the initial procedure, and two underwent the Foker
procedure. All patients were alive following treatment.
Outcome of our patients with type A esophageal atresia
was less than that in the study by Burjonrappa et al. [21].
In our study, the rate of using gastrostomy was
significantly decreased during the second period of study.
Technically, gastrostomy and cervical esophagostomy
were used for long gap patients [22]. In addition, we
used it for ill neonates when anastomosis was technically
impossible. Yen et al. [23] concluded that routine gastro-
stomy is contraindicated when primary anastomosis is
feasible. Early diagnosis and treatment may be the reason
for decreasing use of gastrostomy in our patients. Another
reason for this decline in the number of gastrostomy
procedures may be the decreasing number of newborn
with long gap atresia. However, in this study, we had no
reliable data regarding newborn with long gap atresia to
draw a conclusion. The number of patients who under-
went cervical esophagostomy was decreased in our study.
In our study, cervical esophagostomy was performed for
6.09% (12/197) of patients. In the study by Peyvasteh
et al. [24], 6.75% of patients underwent cervical
esophagostomy. In our study, gastrostomy was used for
79.29% of patients but in Peyvasteh et al.’s [24] study,
gastrostomy was performed for 17.56% (13 of 74)
patients. In addition, the mortality rate (50%) in our
study was higher than that in Peyvasteh et al.’s [24] study.
This difference may be due to difference in the condition
of patients. It appears that our patients had more severe
illness than their patients.
In our study, of the 198 patients 109 (55.05%) patients
had associated congenital anomalies. Congenital heart
disease and gastrointestinal anomalies were the most
frequent associated anomalies. The frequency of cardiac
anomalies in our study was less than that in the
Chittmittrapap et al.’s study [25]. Associated congenital
anomalies were detected in 47.8% of patients in the study
from Saudi Arabia [26]. In the Manning et al.’s [27] study,
cardiovascular and gastrointestinal anomalies were the
most common associated major anomalies. The most
common minor anomalies were limb defect and skeletal
anomalies [27]. Cardiac anomalies, imperforate anus,
limb anomalies, and chromosomal anomalies were the
most common anomalies in the study by Zhang et al. [15].
Overall rate of anomalies in our study was similar to other
studies [28]; however, there was difference between
studies regarding the rate of each anomaly.
Conclusion
Mortality rate has decreased in our hospitals, but it
remains higher than other studies. The rate of gastro-
stomy decreased during the second period of study. The
rate of NICU admission was significantly higher during
the second period of study. Overall rate of anomalies in
our study was similar to other study. However, mortality
has decreased in our hospitals, but the mortality rate in
our country is higher than in other countries. Our
experiences and equipments should be improved to
lessen the mortality.
Limitation
This study is retrospective and we had no reliable data
regarding anomalies.
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